Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies

Table 2 Changes in ILD patients at admission and the last follow-up

Patients, gender, age	Admission						Last visit
Patients, gender, age	MMT	CK	FVC (%)	FEV1/FVC (%)	DLCO (%)	HRCT	MMT	CK	FVC (%)	FEV1/FVC (%)	DLCO (%)	HRCT	Fellow-up (months)
P1, F, 48	65	7203	71	81	63	GGO	78	1180	59	82	58	GGO, reticulation	43
P2, F, 66	72	1436	99	71	88	Reticulation	80	25	114	72	74	Reticulation	6
P3, F, 41	68	4113	82	85	82	IST	70	51	84	100	66	IST	40
P4, F, 51	70	2748	71	86	58	Reticulation	72	171	69	88	68	Reticulation	78
P5, F, 24	56	6367	69	83	70	Reticulation, IST	75	43	77	100	49	Reticulation, IST	23
P6, M, 55	55	1620	83	90	64	GGO, consolidation	63	661	83	93	65	GGO, consolidation	9
P7, F, 50	80	1176	90	85	50	Reticulation	80	1702	97	87	56	Reticulation, IST, TB,	48
P8, F, 52	75	535	70	83	58	Reticulation, IST	80	34	65	83	55	Consolidation, Patchy shadows	6
P9, M, 54	45	3196	57	96	71	GGO, patchy shadows, PT	44	2459	59	81	60	GGO, PT, patchy shadows	7

GGO, Ground glass opacity; IST, interlobular septal thickening; TB, traction bronchiectasis; MMT, manual muscle test; PT, pleural thickening

ISSN: 1471-2466